insert therapeutics unidym tego bio sciences science research anti-cancer drugs RNAi therapeutics carbon-based electronics nanotechnology arrowhead pasadena california nasdaq arwr nanotechnology arrowhead pasadena california nasdaq arwr

Arrowhead Press Releases

February 11, 2010

Arrowhead Reports Fiscal 2010 First Quarter Financial Results

PASADENA, Calif. – Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its fiscal 2010 first quarter ended December 31, 2009.

more...
February 8, 2010

Arrowhead Research to Report First Quarter Fiscal 2010 Financial Results and Host Conference Call on Thursday,
February 11, 2010

PASADENA, Calif. - Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it will report its financial results for the fiscal 2010 first quarter ended December 31, 2009, on Thursday, February 11, 2009 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate in the conference call, please dial 877-941-4774 or 480-629-9760. Investors may also access a live audio webcast of this conference call on the Company's website.

more...
February 8, 2010

Unidym Adds Malcolm Gillis, Ph.D. to Board of Directors

Sunnyvale, CA - Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), today announced that Malcolm Gillis, Ph.D. has been appointed to its Board of Directors. Dr. Gillis served as the President of William Marsh Rice University from 1993 until 2004 and guided Rice to become a leader in the then emerging field of nanoscience. His distinguished academic career focused on economics and environmental public policy and included appointments at Duke University and Harvard University.

more...
February 3, 2010

Arrowhead appoints Chief Financial Officer

Pasadena, CA - Arrowhead Research Corporation (NASDAQ: ARWR) today announced that Ken Myszkowski has been appointed as the Company's Chief Financial Officer. Mr. Myszkowski brings to Arrowhead a broad range of finance and accounting experience spanning two decades in both the public and private sectors, including, most recently, senior level positions at two publicly traded energy companies and, earlier in his career, in two early stage technology companies.

more...
February 2, 2010

Arrowhead's Portfolio Company, Nanotope, Publishes Preclinical Data Demonstrating Cartilage Regeneration

PASADENA, Calif. - February 2, 2010 - Arrowhead Research Corporation (NASDAQ: ARWR) today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model.

more...
February 1, 2010

Unidym Announces Joint Venture to Market Printable CNT Electronics in Korea

Sunnyvale, CA – Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), today announced that it has signed a definitive agreement to create a joint venture partnership with Wisepower, a publicly traded Korean company (KOSDAQ: 040670), to market and co-develop Unidym’s proprietary film and electronic ink products into the Korean touch panel and display industries.

more...
January 20, 2010

Unidym Completes Licensing Agreements to Expand Use of its Carbon Nanotube IP in Diverse Array of Applications

Sunnyvale, CA – Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), today announced that it has completed three licensing agreements for its nanotechnology intellectual property (IP) for use in applications such as aerospace and military products.

more...
December 28, 2009

Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to Luna Innovations

PASADENA, California – December 28, 2009 – Arrowhead Research Corporation (NASDAQ: ARWR) today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc. (Nasdaq: LUNA), a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines.

more...
December 23, 2009

Arrowhead Reports Fiscal 2009 Fourth Quarter and Full-Year Financial Results

PASADENA, Calif. – December 22, 2009 – Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its fiscal 2009 fourth quarter and full-year ended September 30, 2009.

more...
December 21, 2009

Arrowhead Research to Report Fiscal 2009 Fourth Quarter and Year-End Financial Results and Host Conference Call on Tuesday, December 22, 2009

PASADENA, Calif. — December 21, 2009 — Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it will report its financial results for the fiscal 2009 fourth quarter and year ended September 30, 2009, on Tuesday, December 22, 2009 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).

more...
December 17, 2009

Arrowhead Announces $3.2 Million Private Placement

PASADENA, California - December 17, 2009 - Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has raised approximately $3.2 million in gross proceeds from a private placement of approximately 5.0 million units.

more...
December 14, 2009

Arrowhead Subsidiary, Unidym, Enters Into Joint Development Agreement With a Major Liquid Crystal Display (LCD) Manufacturer For Glass Based Liquid Crystal Displays

Sunnyvale, CA - Unidym, Inc, a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), announced today that it has entered into a joint development agreement with a major liquid crystal display (LCD) manufacturer.

more...
December 2, 2009

Unidym and Nano-C Enter Exclusive License Agreement for Fullerene Derivatives Used in Solar Cells

Sunnyvale, CA - December 2, 2009 - Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), announced today that it has entered an exclusive license agreement with Nano-C for patents covering fullerene derivatives. The license provides Nano-C exclusive rights to U.S. Patent No. 5,739,376 and foreign counterparts in the field of photovoltaics.

more...
November 11, 2009

Arrowhead Subsidiary Unidym, Inc. Enters into Third Year of Joint Development Program with Samsung Electronics for Flexible Displays

Pasadena, CA – November 11, 2009 – Arrowhead Research Corporation (NASDAQ: ARWR) announced today that its majority owned subsidiary, Unidym, Inc., has entered into a joint development agreement with Samsung Electronics Co., Ltd., a leading maker of liquid crystal display (LCD) panels, to extend their successful collaboration into a third year.

more...
November 4, 2009

Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that its majority owned subsidiary, Calando Pharmaceuticals, Inc., has appointed Mostafa Analoui, Ph.D., and Bruce D. Given, MD, to its Board of Directors.

more...
November 3, 2009

Arrowhead CEO Provides Update on Company Strategy and Operations

Arrowhead Research Corporation (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company's shareholders:

more...
September 18, 2009

Arrowhead Receives NASDAQ Deficiency Notice Related to Minimum Bid Price

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has received a deficiency letter from the NASDAQ Stock Market indicating that based on the Company’s closing bid price for the last 30 consecutive business days, the Company does not comply with the $1.00 minimum bid price as set forth in NASDAQ Marketplace Rule 5550(a)(2).

more...
August 12, 2009

Arrowhead Regains Compliance with NASDAQ Listing Requirements

Arrowhead Research Corporation (NASDAQ: ARWR)  today announced that it has received notification from the NASDAQ Stock Market that the Company has regained compliance with the minimum of $2.5 million in stockholders’ equity requirement for continued listing on the NASDAQ Capital Market, pursuant to NASDAQ Marketplace Rule 4310(c)(3).

more...
August 10, 2009

Arrowhead Reports Third Quarter Fiscal 2009 Financial Results

Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its third fiscal quarter ended June 30 2009.

more...
August 7, 2009

Arrowhead Announces Completion of $2.76 Million Private Placement

Arrowhead Research Corporation today announced that it has completed a second and final closing of its private offering with selected institutional and accredited investors bringing the proceeds of the offering to a total of $2.76 million.

more...
August 4, 2009

Arrowhead Research to Report Fiscal Third Quarter 2009 Financial Results and Host Conference Call on Monday, August 10, 2009

PASADENA, Calif. — August 4, 2009 — Arrowhead Research Corporation (NASDAQ: ARWR today announced that it will report its financial results for the third quarter of fiscal 2009 ended June 30, 2009, on Monday, August 10, 2009 at 4:30 p.m. ET (1:30 p.m. PT). To participate in the conference call, please dial 888-846-5003 or 480-629-9856. Investors may also access a live audio webcast of this conference call on the Company's website at www.arrowheadresearch.com.

more...

Click here to view the archives